“there is a new air about india” islands of excellence in : educationagriculture...
TRANSCRIPT
““THERE IS A NEW AIR ABOUT THERE IS A NEW AIR ABOUT INDIA”INDIA”
ISLANDS OF EXCELLENCE IN :ISLANDS OF EXCELLENCE IN :
• EDUCATIONEDUCATION AGRICULTUREAGRICULTURE• HEALTHCAREHEALTHCARE RESEARCH RESEARCH
INDUSTRYINDUSTRY
ENGLISH`S NEW SUPERPOWERENGLISH`S NEW SUPERPOWER
WITH AN ENGLISH-SPEAKING POPULATION WITH AN ENGLISH-SPEAKING POPULATION NOW LIKELY TO HAVE SURPASSED THAT OF NOW LIKELY TO HAVE SURPASSED THAT OF BRITAIN AND THE US, INDIA IS SET TO BRITAIN AND THE US, INDIA IS SET TO BECOME A LINGUISTIC SUPER POWER.BECOME A LINGUISTIC SUPER POWER.
INDIA CURRENTLY HAS A SPECIAL PLACE IN INDIA CURRENTLY HAS A SPECIAL PLACE IN THE ENGLISH LANGUAGE RECORD BOOKS – THE ENGLISH LANGUAGE RECORD BOOKS – AS THE COUNTRY WITH THE LARGEST AS THE COUNTRY WITH THE LARGEST ENGLISH SPEAKING POPULATION IN THE ENGLISH SPEAKING POPULATION IN THE WORLD. TEN YEARS AGO THAT RECORD WAS WORLD. TEN YEARS AGO THAT RECORD WAS HELD BY THE US . NOT ANY MORE !HELD BY THE US . NOT ANY MORE !
INDIA ON TOPINDIA ON TOP
AMONG THE FASTEST GROWING ECONOMIESAMONG THE FASTEST GROWING ECONOMIES
““FOURTH LARGEST ECONOMY”:FOURTH LARGEST ECONOMY”:WASHINGTON POSTWASHINGTON POST
AMONG THE TOP FOUR FDI DESTINATIONSAMONG THE TOP FOUR FDI DESTINATIONS
MORE FII INTO INDIAN EQUITIES THAN CHINA, KOREA MORE FII INTO INDIAN EQUITIES THAN CHINA, KOREA & TAIWAN COMBINED& TAIWAN COMBINED
“ “ POTENTIALLY BIGGER LONG-TERM GROWTH STORY POTENTIALLY BIGGER LONG-TERM GROWTH STORY THAN CHINA ”: GOLDMANTHAN CHINA ”: GOLDMAN SACHSSACHS
INDIA ON TOPINDIA ON TOP
ECONOMIST INTELLIGENCE UNIT (SEPT 04)ECONOMIST INTELLIGENCE UNIT (SEPT 04)CENTERS OF OVERSEAS INVESTMENT :CENTERS OF OVERSEAS INVESTMENT :
%% COUNTRYCOUNTRY
3939 CHINACHINA
2929 USAUSA
2828 INDIAINDIA
“ INDIA AN R & D SPOT “
INDIA ON TOPINDIA ON TOP
LARGEST MILKY WAY !LARGEST MILKY WAY !
90 MILLION TONS IN 200490 MILLION TONS IN 2004 20 MILLION TONS MORE THAN USA,20 MILLION TONS MORE THAN USA,
THE SECOND BIG PRODUCERTHE SECOND BIG PRODUCER
INDIA ON TOPINDIA ON TOP
NO.1 IN MANY AREAS !NO.1 IN MANY AREAS !
SUGAR PRODUCTION SUGAR PRODUCTION BANANA, PAPAYA, MANGOBANANA, PAPAYA, MANGO EGG PLANT, CAULIFLOWER, PEASEGG PLANT, CAULIFLOWER, PEAS SPICES, COCONUT, ARECNUTSPICES, COCONUT, ARECNUT
INDIA ON TOPINDIA ON TOP
INDIAN BRANDY, BUT GLOBAL KICKINDIAN BRANDY, BUT GLOBAL KICK McDowell's NO.1 WORLD`S TOP SELLING McDowell's NO.1 WORLD`S TOP SELLING
BRAND, DISPLACES E & J BRAND, DISPLACES E & J
INDIAN MULTINATIONALSINDIAN MULTINATIONALS
DESI COMPANIES GOBBLING UP FOREIGN DESI COMPANIES GOBBLING UP FOREIGN ENTITIES !ENTITIES !
IN 2003, 40 COMPANIES TAKEN OVERIN 2003, 40 COMPANIES TAKEN OVER TATA TEA : TETLEY TEATATA TEA : TETLEY TEA TATA : DAEWOOTATA : DAEWOO ESSEL PACKAGING : PROPAK (SWISS)ESSEL PACKAGING : PROPAK (SWISS) BIGGEST CARBON BLACK : BIGGEST CARBON BLACK :
KUMARAMANGALAM BIRLAKUMARAMANGALAM BIRLA
INDIA AN R & D POWERHOUSEINDIA AN R & D POWERHOUSE
ENGLISH SPEAKING KNOWLEDGE ENGLISH SPEAKING KNOWLEDGE WORKERSWORKERS
30%-50% COST SAVING : SWATI 30%-50% COST SAVING : SWATI PIRAMALPIRAMAL
1/51/5THTH -1/7 -1/7THTH COST IN EUROPE : RANBAXY COST IN EUROPE : RANBAXY BANGALORE : FASTEST GROWING BANGALORE : FASTEST GROWING
BIOCLUSTER IN ASIABIOCLUSTER IN ASIA
THE BIOTECH INDUSTRYTHE BIOTECH INDUSTRY MORE NEW DRUG APPROVALS FROM FDA BY MORE NEW DRUG APPROVALS FROM FDA BY
BT COMPANIES THAN PHARMA IN 2004BT COMPANIES THAN PHARMA IN 2004 USA:THE BIRTHPLACE OF MODERN BT USA:THE BIRTHPLACE OF MODERN BT
TOWER OVER THE FIELD !TOWER OVER THE FIELD ! 4400 BT FIRMS WORLDWIDE4400 BT FIRMS WORLDWIDE 2200 US FIRMS PUBLICLY TRADED2200 US FIRMS PUBLICLY TRADED 2004 REVENUES $43 BILLION2004 REVENUES $43 BILLION AMERICAN INDUSTRY RAISED $17 BILLION AMERICAN INDUSTRY RAISED $17 BILLION
FROM PUBLIC & PRIVATE FUNDS IN 2004 FROM PUBLIC & PRIVATE FUNDS IN 2004 (5 TIMES THAT OF EUROPE !)(5 TIMES THAT OF EUROPE !) GERMAN BT FLOUNDEREDGERMAN BT FLOUNDERED BRITISH BT BRUISED & BLOODIED BUT BRITISH BT BRUISED & BLOODIED BUT
UNBOWED (ERNST & YOUNG)UNBOWED (ERNST & YOUNG)
ASIAN BIOTECHASIAN BIOTECH
DOMINATED BY AUSTRALIA :$2 BN, i.e. 75 % DOMINATED BY AUSTRALIA :$2 BN, i.e. 75 % OF ASIAN REVENUEOF ASIAN REVENUE
INTERESTING COMPANIES SPRINGING UP IN INTERESTING COMPANIES SPRINGING UP IN INDIA, CHINA, SINGAPORE INDIA, CHINA, SINGAPORE
SINGAPORE BIOPOLISSINGAPORE BIOPOLIS
TO HOST 2000 SCIENTISTS FROM AROUND TO HOST 2000 SCIENTISTS FROM AROUND THE WORLD INCLUDING ALLEN COLEMAN THE WORLD INCLUDING ALLEN COLEMAN OF DOLLY FAMEOF DOLLY FAME
R & D BUDGET OF $ 7 BILLION OVER 5 YEARSR & D BUDGET OF $ 7 BILLION OVER 5 YEARS
500 STUDENTS SENT ABROAD FOR Ph.D500 STUDENTS SENT ABROAD FOR Ph.D
INDIAN BIOTECH SECTORINDIAN BIOTECH SECTOR
ABLE (ASSOC. BIOTECH LED ENTERPRISES)ABLE (ASSOC. BIOTECH LED ENTERPRISES) REVENUE - $ 1 BILLIONREVENUE - $ 1 BILLION FIVE FOLD INCREASE ($ 5 BILLION) BY 2010FIVE FOLD INCREASE ($ 5 BILLION) BY 2010 EMPLOYED 9000 S & T PERSONNEL IN 2004EMPLOYED 9000 S & T PERSONNEL IN 2004 40% INCREASE IN 200540% INCREASE IN 2005
PHARMA EXPORTS TO GROW PHARMA EXPORTS TO GROW TO $6 bnTO $6 bn
INDIA IS ONE OF THE TOP FIVE INDIA IS ONE OF THE TOP FIVE MANUFACTURERS OF BULK DRUGS IN THE MANUFACTURERS OF BULK DRUGS IN THE
WORLD !WORLD !
PHARMA EXPORTS $6 bn BY 2015 FROM THE CURRENT LEVEL PHARMA EXPORTS $6 bn BY 2015 FROM THE CURRENT LEVEL OF LESS THAN $2 bnOF LESS THAN $2 bn
THE R & D ACTIVITIES ARE TARGETED BOTH AT NEW DRUG THE R & D ACTIVITIES ARE TARGETED BOTH AT NEW DRUG DISCOVERY RESEARCH AND NOVEL DRUG DELIVERY DISCOVERY RESEARCH AND NOVEL DRUG DELIVERY SYSTEMS (NDDS). THE MAJOR COMPANIES INVESTED OVER SYSTEMS (NDDS). THE MAJOR COMPANIES INVESTED OVER Rs. 1000 CRORES LAST YEAR.Rs. 1000 CRORES LAST YEAR.
INDIAN BIOTECH SECTORINDIAN BIOTECH SECTOR
SERUM INSTITUTESERUM INSTITUTETHE VACCCINE GIANT !THE VACCCINE GIANT !
LARGEST INDIAN BT COMPANYLARGEST INDIAN BT COMPANY LARGEST VACCINE PRODUCER IN THE WORLDLARGEST VACCINE PRODUCER IN THE WORLD PRODUCES 675 m DOSAGES PER DAYPRODUCES 675 m DOSAGES PER DAY DISTRIBUTED AND USED IN 137 COUNTRIES OF THE DISTRIBUTED AND USED IN 137 COUNTRIES OF THE
WORLD (W.H.O)WORLD (W.H.O) 30% OF WORLD`S CHILDREN PROTECTED BY30% OF WORLD`S CHILDREN PROTECTED BY SERUM INTITUTE`S VACCINESERUM INTITUTE`S VACCINE
INDIAN BIOTECH SECTORINDIAN BIOTECH SECTOR
INDIAN VACCINE IMPACT INDIAN VACCINE IMPACT
HAFFKINE INSTITUTE , MUMBAIHAFFKINE INSTITUTE , MUMBAI PIONEER IN POLIO VACCINE PRODUCTION PIONEER IN POLIO VACCINE PRODUCTION IMMUNISED 150 m CHILDRENIMMUNISED 150 m CHILDREN ERADICATED POLIOERADICATED POLIO HEPATITIS B VACCINESHEPATITIS B VACCINES SHANTA BIOTECHSHANTA BIOTECH BHARAT BIOTECHBHARAT BIOTECH WOCKARDT, REDDY`SWOCKARDT, REDDY`S
INDIAN BIOTECH SECTORINDIAN BIOTECH SECTOR
NEUTRACEUTICALSNEUTRACEUTICALS
PARRY NEUTRACEUTICALSPARRY NEUTRACEUTICALS
SPIRULINA, DUNALIELLASPIRULINA, DUNALIELLA
-CAROTENE, ASTAXANTHIN-CAROTENE, ASTAXANTHIN THAPARTHAPAR ABL BIOTECHNOLOGIESABL BIOTECHNOLOGIES SAMY CHEMICALSSAMY CHEMICALS
INDIAN BIOTECH SECTORINDIAN BIOTECH SECTOR
EMERGING INTERNATIONAL HUB FOR EMERGING INTERNATIONAL HUB FOR CONTRACT RESEARCHCONTRACT RESEARCH
MANY START-UP COMPANIES IN THE LAST MANY START-UP COMPANIES IN THE LAST FOUR YEARSFOUR YEARS
BPO RPO BPO RPO CRAM CRAM RESEARCH & RESEARCH & MANUFACTURINGMANUFACTURING
BIOCON (BANGALORE) SERUM INSTITUTE BIOCON (BANGALORE) SERUM INSTITUTE (PUNE), PANACEA BIOTECH (DELHI), (PUNE), PANACEA BIOTECH (DELHI), NICHOLAS PIRAMAL (MUMBAI), NOVO NICHOLAS PIRAMAL (MUMBAI), NOVO NORDSIK (BANGALORE)NORDSIK (BANGALORE)
APOLLO HOSPITAL ENTERPRISESAPOLLO HOSPITAL ENTERPRISES
CHENNAI, DELHI, HYDERABADCHENNAI, DELHI, HYDERABAD Rs 150 CRORE REVENUE IN 2004-2005Rs 150 CRORE REVENUE IN 2004-2005 40% REVENUE FROM CARDIAC CARE40% REVENUE FROM CARDIAC CARE 39% REVENUE FROM PHARMA BUSINESS39% REVENUE FROM PHARMA BUSINESS TO SET UP SEVEN 120 BED HOSPITALS IN MINI-TO SET UP SEVEN 120 BED HOSPITALS IN MINI-
METROSMETROS MOU WITH JOHNS HOPKINS MEDICINE MOU WITH JOHNS HOPKINS MEDICINE
INTERNATIONALINTERNATIONAL TO SET UP CENTRAL REFERENCE LABS IN CHENNAI, TO SET UP CENTRAL REFERENCE LABS IN CHENNAI,
HYDERABAD AND DELHI - HIGH END CLINICAL HYDERABAD AND DELHI - HIGH END CLINICAL TESTINGTESTING
TO SET UP INSTITUTE OF MINIMAL INVASIVE TO SET UP INSTITUTE OF MINIMAL INVASIVE SURGERYSURGERY
COLLABORATIVE R & DCOLLABORATIVE R & D
RANBAXY : MEDICINES FOR MALARIA RANBAXY : MEDICINES FOR MALARIA VENTURE (MMV) GENEVAVENTURE (MMV) GENEVA
ANTIMALARIAL MOLECULE - Rbx 11160ANTIMALARIAL MOLECULE - Rbx 11160 RANBAXY : GLAXO SMITH KLINERANBAXY : GLAXO SMITH KLINE Dr. REDDY`S, ZYDUS CADILA,Dr. REDDY`S, ZYDUS CADILA, NICHOLAS PIRAMAL (EMERGING NICHOLAS PIRAMAL (EMERGING
ACTIVITIES)ACTIVITIES)
BIOCON TIES WITH NOBEX TO BIOCON TIES WITH NOBEX TO DEVELOP ORAL INSULINDEVELOP ORAL INSULIN
BIOCON HAS ENTERED INTO A RESEARCH COLLABORATION BIOCON HAS ENTERED INTO A RESEARCH COLLABORATION WITH NORTH CAROLINA`S NOBEX CORPORATION TO JOINTLY WITH NORTH CAROLINA`S NOBEX CORPORATION TO JOINTLY DEVELOP ORAL INSLIN FOR THE GLOBAL AND INDIAN DEVELOP ORAL INSLIN FOR THE GLOBAL AND INDIAN MARKETMARKET
ORCHID CHEM`S IPR FILE COUNT TOUCHES 200ORCHID CHEM`S IPR FILE COUNT TOUCHES 200
FILINGS FOR NEW DRUGS, DISCOVERY SYSTEMS AT FILINGS FOR NEW DRUGS, DISCOVERY SYSTEMS AT 25% OF TOTAL25% OF TOTAL
FIIS TO HIKE STAKE IN ORCHID CHEMICALSFIIS TO HIKE STAKE IN ORCHID CHEMICALS
ORCHID JOINS PAR PHARMA TO MARKET GENERICS IN ORCHID JOINS PAR PHARMA TO MARKET GENERICS IN USUS
ORCHID WANTS TO CRACK ORAL CEPHALOSPORIN ORCHID WANTS TO CRACK ORAL CEPHALOSPORIN FORMULATIONS MARKETFORMULATIONS MARKET
ORCHID FILES ANDA FOR CEFAZOLINORCHID FILES ANDA FOR CEFAZOLIN
ORCHID CHEMICALS & ORCHID CHEMICALS & PHARMACEUTICALS LTD.PHARMACEUTICALS LTD.
300 SCIENTIFIC PERSONNEL300 SCIENTIFIC PERSONNEL 400 BY 2006400 BY 2006 Rs. 150 CRORES IN R & D DURING LAST 7 Rs. 150 CRORES IN R & D DURING LAST 7
YEARSYEARS FDA/GLP ANIMAL FACILITY, LABSFDA/GLP ANIMAL FACILITY, LABS ANTI-INFLAMATORY, OBESITY, CANCER, ANTI-INFLAMATORY, OBESITY, CANCER,
HERBAL MEDICINEHERBAL MEDICINE TARGET : $1 bn BY 2010TARGET : $1 bn BY 2010 JV IN USA, ITALY , CHINAJV IN USA, ITALY , CHINA
PEP PILL: GLOBAL BIZ FORM 60% OF SALES PEP PILL: GLOBAL BIZ FORM 60% OF SALES NOWNOW
WOCKHARDT EYES ANOTHER EUROPEAN WOCKHARDT EYES ANOTHER EUROPEAN TAKEOVERTAKEOVER
AFTER ACQUIRING THREE EUROPEAN COMPANIES AFTER ACQUIRING THREE EUROPEAN COMPANIES IN THE PAST, IT IS LOOKING TO ACQUIRE ONE MORE IN THE PAST, IT IS LOOKING TO ACQUIRE ONE MORE EUROPEAN COMPANYEUROPEAN COMPANY
WOCKHARDT BUYS GERMAN FIRMWOCKHARDT BUYS GERMAN FIRM* * DRL ACQUIRES TRIGENESIS OF USDRL ACQUIRES TRIGENESIS OF US TORRENT PHARMA TO ACQUIRE GERMAN CO FOR Rs TORRENT PHARMA TO ACQUIRE GERMAN CO FOR Rs
300 CRORE300 CRORE JUBILANT ORGANOSYS ACQUIRES TWO BELGIAN JUBILANT ORGANOSYS ACQUIRES TWO BELGIAN
PHARMA FIRMSPHARMA FIRMS Rs 75 CRORE DEAL TO STRENGTHEN PRESENCE IN Rs 75 CRORE DEAL TO STRENGTHEN PRESENCE IN
EU, ITS MAIN EXPORT MARKETEU, ITS MAIN EXPORT MARKET WYETH SELLS BULK DRUGS PLANT TO RUNWAL WYETH SELLS BULK DRUGS PLANT TO RUNWAL
GROUP FOR Rs 60 CROREGROUP FOR Rs 60 CRORE
NICHOLAS PIRAMAL PLANS BIG DIAGNOSTICS PUSH
HAS SIGNED ALLIANCES WITH DIASYS GMBH, A GERMAN FIRM,HYPOGUARD, A UK-BASED COMPANY PART OF THE MEDISYS
GROUP, AND CHOLESTECH, A US-BASED COMPANY.
STRAND IN DEAL WITH US CO FOR MICROARRAY PLATFORM
HAS ENTERED INTO AN AGREEMENT WITH US MAJOR AFFYMETRIX,
FOR PROVIDING MICROARRAY PLATFORM
MICROARRAYS ARE POWERFUL TOOLS THAT ALLOW SCIENTISTS TO MEASURE AND COMPARE THE EXPRESSION LEVELS OF THOUSANDS OF GENES IN A SINGLE EXPERIMENT.
SHASUN HIKES CONTRACT THRUST
USFDA-COMPLIANT R&D (RESEARCH AND DEVELOPMENT) CENTRE NEAR CHENNAI AT AN INVESTMENT OF ABOUT RS.35 CRORE.
THE NEW FACILITY WOULD HOUSE ABOUT EIGHT LABORATORIES AND NEARLY 300 SCIENTISTS.
MALLADI DRUGS ACQUIRES U.S. FIRM
SUN PHARMA’S PLANS FOR US BUY GET A BOOST
ZYDUS CADILA UPPING PRESENCE ABROAD
CLINICAL RESEARCHCLINICAL RESEARCH
$ 1 BILLION BY 2008$ 1 BILLION BY 2008 BIOCON – CLINIGENEBIOCON – CLINIGENE RELIANCE CLINICAL RESEARCH SERVICES RELIANCE CLINICAL RESEARCH SERVICES
QUINTILES : WORLD`S QUINTILES : WORLD`S LARGEST CLINICAL RESEARCH LARGEST CLINICAL RESEARCH
OUTFITOUTFIT
IN INDIA SINCE 1997IN INDIA SINCE 1997 MUMBAI, AHMEDABAD, BANGALOREMUMBAI, AHMEDABAD, BANGALORE 900 PEOPLE 900 PEOPLE 2000 PEOPLE BY 20082000 PEOPLE BY 2008
MERCK & CO $40 bn US GIANTMERCK & CO $40 bn US GIANT
WITH APOTHECARIES LTDWITH APOTHECARIES LTD
(DELHI, CRO)(DELHI, CRO)
CLINICAL TRIALS ACROSS 20 CENTERS CLINICAL TRIALS ACROSS 20 CENTERS IN INDIA FOR ANTIBIOTIC , CANCERIN INDIA FOR ANTIBIOTIC , CANCER
SRL-RANBAXY IN TIE-UP WITH UK SRL-RANBAXY IN TIE-UP WITH UK HOSPITALS GROUPHOSPITALS GROUP
PATHOLOGY TESTING IN INDIA PATHOLOGY TESTING IN INDIA
NINE LABS IN INDIA, MAIN LAB IN NINE LABS IN INDIA, MAIN LAB IN MUMBAIMUMBAI
CCMB SPOTS GENETIC JACKPOT IN INDIA
WITH ITS 4,635 ANTHROPOLOGICALLY WELL-DEFINED ENDOGAMOUS POPULATIONS –
OF WHICH 532 ARE TRIBES, INCLUDING 72 PRIMITIVE POPULATIONS, INDIA IS A BIGGER LABORATORY THAN ICELAND TO STUDY POPULATION/COMMUNITY-BASED GENETIC DISEASES.
BIOCON CHAIRMAN KIRAN MAZUMDAR-SHAW ARGUES THAT THE COUNTRY’S UNIQUE GENE POOLS ARE “GOLD MINES”.
ABOUT 50 MILLION INDIVIDUALS ARE AFFECTED WITH GENETIC DISEASES IN INDIA.
GSK BIO TARGETS INDIA FOR R & DGSK BIO TARGETS INDIA FOR R & D
GLAXO SMITH KLINE BIOLOGICALS, THE VACCINE GLAXO SMITH KLINE BIOLOGICALS, THE VACCINE BUSINESS OF GLAXO SMITH KLINE (GSK), WILL BUSINESS OF GLAXO SMITH KLINE (GSK), WILL MAKE INDIA A GLOBAL HUB FOR CLINICAL MAKE INDIA A GLOBAL HUB FOR CLINICAL RESEARCH AND DEVELOPMENTRESEARCH AND DEVELOPMENT
HI-TECH VACCINES FOR AIDS, DENGUE, MALARIA HI-TECH VACCINES FOR AIDS, DENGUE, MALARIA AND TBAND TB
THE TB VACCINE TO START PHASE II TRIALS IN THE TB VACCINE TO START PHASE II TRIALS IN INDIAINDIA
PEP PILL:SANDOZ INVESTS $13M IN THIRD FACILITY IN INDIA.
ROCHE DIAGNOSTICS EYES INDIA FOR PRODUCTION, R&D.
GE HEALTHCAREGE HEALTHCARE
SOME OF US GROW UP TO BE ENGINEERS OR SOME OF US GROW UP TO BE ENGINEERS OR DOCTORSDOCTORS
SOME OF US GROW UP TO BE BOTH !SOME OF US GROW UP TO BE BOTH !
MEDICAL IMAGING AND INFORMATION TECHNOLOGIESMEDICAL IMAGING AND INFORMATION TECHNOLOGIES MEDICAL DIAGNOSTICSMEDICAL DIAGNOSTICS PATIENT MONITORING SYSTEMS, DISEASE RESEARCH, PATIENT MONITORING SYSTEMS, DISEASE RESEARCH,
DRUG DISCOVERY AND BIOPHARMACEUTICALSDRUG DISCOVERY AND BIOPHARMACEUTICALS EARLY DETECTION OF DISEASE AND TREATMENT OF EARLY DETECTION OF DISEASE AND TREATMENT OF
CONDITIONS LIKE CANCER, ALZHEIMER`S AND CONDITIONS LIKE CANCER, ALZHEIMER`S AND CARDIOVASCULAR DISEASESCARDIOVASCULAR DISEASES
GTO INDIA HAS OVER 90 PATENTS TO ITS CREDIT AND OVER GTO INDIA HAS OVER 90 PATENTS TO ITS CREDIT AND OVER 100 INVENTION DISCLOSURES IN THE YEAR 2003 ALONE100 INVENTION DISCLOSURES IN THE YEAR 2003 ALONE..
GENETICS SPECIALTIES GENETICS SPECIALTIES LAUNCHEDLAUNCHED
CANCER GENETICS, A BIOTECHNOLOGY CANCER GENETICS, A BIOTECHNOLOGY COMPANY BASED IN THE US, HAS COMPANY BASED IN THE US, HAS ANNOUNCED THE LAUNCH OF GENETICS ANNOUNCED THE LAUNCH OF GENETICS SPECIALTIES IN BANGALORE.SPECIALTIES IN BANGALORE.
GENETIC DIAGNOSTIC TOOL FOR INDIAN GENETIC DIAGNOSTIC TOOL FOR INDIAN HEALTH MARKETHEALTH MARKET
GM RESEARCH THRIVING IN GM RESEARCH THRIVING IN INDIAN ACADEMIAINDIAN ACADEMIA
WHEAT, RICE, SUGARCANE, TOBACCO BANANA, WHEAT, RICE, SUGARCANE, TOBACCO BANANA, VEGIES, POTATO, OIL SEEDSVEGIES, POTATO, OIL SEEDS
$15 MILLION/YEAR GOVT. LABS$15 MILLION/YEAR GOVT. LABSVsVs
$ 10 MILLION/ YEAR BY SEED COST,$ 10 MILLION/ YEAR BY SEED COST,20 GOVT. INSTITUTES ON 16 CROPS20 GOVT. INSTITUTES ON 16 CROPS
SEVERAL PRIVATE COMPANIES ON 10 CROPSSEVERAL PRIVATE COMPANIES ON 10 CROPS IARI, JNU, NCPGR, U. DELHI, MKU, SRI (CBE), NBRI, IARI, JNU, NCPGR, U. DELHI, MKU, SRI (CBE), NBRI,
TNAU, ICRISAT.TNAU, ICRISAT.
ICRISAT, HYDERABADICRISAT, HYDERABAD
WORLD`S FIRST TRANSGENIC GROUNDNUT: WORLD`S FIRST TRANSGENIC GROUNDNUT: RESISTANCE TO INDIAN PEANUT CLAMP RESISTANCE TO INDIAN PEANUT CLAMP VIRUS ; ROSETTE DISEASE IN AFRICAVIRUS ; ROSETTE DISEASE IN AFRICA
TRANSGENIC BT PIGEONPEA, CHICKPEATRANSGENIC BT PIGEONPEA, CHICKPEA
GM CROPS RESEARCH IN INDIAGM CROPS RESEARCH IN INDIA
RALLIS INDIA (TATAS)RALLIS INDIA (TATAS) RASI, NUSIVEEDU, NAVBHARAT, ANKUR, RASI, NUSIVEEDU, NAVBHARAT, ANKUR,
METAHELIX, AVESTHAGEN METAHELIX, AVESTHAGEN INDO-AMERICAN HYBRID SEEDSINDO-AMERICAN HYBRID SEEDS MONSANTO/MAHICOMONSANTO/MAHICO SYNGENTA (SWISS)SYNGENTA (SWISS) BAYER/ PROAGRO(GERMANY)BAYER/ PROAGRO(GERMANY)
GM COTTON WILL TREBLEGM COTTON WILL TREBLE
TO 3.3 m Acres !TO 3.3 m Acres !(FROM 1.0 m Acres)(FROM 1.0 m Acres)
INDIA LARGEST COTTON ACREAGEINDIA LARGEST COTTON ACREAGE BUT VERY LOW PRODUCTION/ACREBUT VERY LOW PRODUCTION/ACRE GM SURGE MOSTLY ILLEGAL PLANTINGGM SURGE MOSTLY ILLEGAL PLANTING
THE LAS VEGAS PILLTHE LAS VEGAS PILL
PFIZER`S ANGINA DRUG TEST !PFIZER`S ANGINA DRUG TEST ! MALE VOLUNTEERS NOTED UNUSUAL MALE VOLUNTEERS NOTED UNUSUAL
CONSEQUENCECONSEQUENCE COMPOUND UK - 92480 BECAME COMPOUND UK - 92480 BECAME VIAGRAVIAGRA USE OF DOPAMINE AGONISTS : COMPULSIVE USE OF DOPAMINE AGONISTS : COMPULSIVE
GAMBLERS, ALCOHOLICS, GLUTTONS, SEX GAMBLERS, ALCOHOLICS, GLUTTONS, SEX PESTSPESTS
BORED WITH BREAD AND BUTTER BORED WITH BREAD AND BUTTER BIOTECH !BIOTECH !
GO MAKE GREAT WINES !GO MAKE GREAT WINES !
SIX BANKERS (INCLUDING TWO INDIANS) SIX BANKERS (INCLUDING TWO INDIANS) LEGENDARY MEAL AT CELEBRATED CHEF LEGENDARY MEAL AT CELEBRATED CHEF GORDON RAMSAY`S PETRUS RESTAURANT IN GORDON RAMSAY`S PETRUS RESTAURANT IN LONDON: SPLASHED £ 44000LONDON: SPLASHED £ 44000
CERTIFIED MOST EXPENSIVE MEAL BY CERTIFIED MOST EXPENSIVE MEAL BY GUINESS BOOK OF RECORDSGUINESS BOOK OF RECORDS
1947 CHATEAU PETRUS BORDEAUX : £12300 1947 CHATEAU PETRUS BORDEAUX : £12300 (Rs.10 LAKHS)(Rs.10 LAKHS)
TWO WINES : £ 11600 AND £ 9400TWO WINES : £ 11600 AND £ 9400
NICHOLAS PIRAMAL PLANS BIG DIAGNOSTICS PUSH
HAS SIGNED ALLIANCES WITH DIASYS GMBH, A GERMAN FIRM,HYPOGUARD, A UK-BASED COMPANY PART OF THE MEDISYS
GROUP, AND CHOLESTECH, A US-BASED COMPANY.
INDIA ON TOPINDIA ON TOPRELIANCE INDUSTRIES IS THE WORLD`S :RELIANCE INDUSTRIES IS THE WORLD`S :
22NDND LARGEST PRODUCER OF POLYFIBER AND YARN LARGEST PRODUCER OF POLYFIBER AND YARN 33RDRD LARGEST PRODUCER OF PARAXYLENE LARGEST PRODUCER OF PARAXYLENE 55THTH LARGEST PRODUCER OF PURIFIED TEREPTHALIC ACID (PTA) LARGEST PRODUCER OF PURIFIED TEREPTHALIC ACID (PTA) IT COMBINES THE PEPTIDE PRODUCTION CAPABILITIES OF BIOCON WITH IT COMBINES THE PEPTIDE PRODUCTION CAPABILITIES OF BIOCON WITH
THE PEPTIDE BASED ORAL-DELIVERY TECHNOLOGY OF NOBEX.THE PEPTIDE BASED ORAL-DELIVERY TECHNOLOGY OF NOBEX.
BIOCON TIES UP WITH VACCINEX FOR ANTIBODIESBIOCON TIES UP WITH VACCINEX FOR ANTIBODIES
BIOCON WITH ROCHESTER (NEW YORK) - BASED VACCINEX TO PURSUE BIOCON WITH ROCHESTER (NEW YORK) - BASED VACCINEX TO PURSUE DEVELOPMENT OF THERAPEUTIC MONOCLONAL ANTIBODIES (MAbs) TO DEVELOPMENT OF THERAPEUTIC MONOCLONAL ANTIBODIES (MAbs) TO ADD TO THEIR DISCOVERY PIPELINE.ADD TO THEIR DISCOVERY PIPELINE.
GLOBAL PROJECTED SALES OF MAbs IS EXPECTED TO TOUCH $13 bn BY GLOBAL PROJECTED SALES OF MAbs IS EXPECTED TO TOUCH $13 bn BY 20102010
THE SCRIPTING OF INDIA NO.1THE SCRIPTING OF INDIA NO.1
THE LIST OF DESI COS POSSESSING WORLD CLASS SIZE AND SCALES GROWINGTHE LIST OF DESI COS POSSESSING WORLD CLASS SIZE AND SCALES GROWING
UB GROUP, WHICH WITH THE ACQUITION OF SHAW WALLACE HAS BECOME THE UB GROUP, WHICH WITH THE ACQUITION OF SHAW WALLACE HAS BECOME THE SECOND LARGEST LIQUOR COMPANY IN THE WORLD AFTER DIAGEOSECOND LARGEST LIQUOR COMPANY IN THE WORLD AFTER DIAGEO
HERO HONDA IS SET TO END THE CURRENT FISCAL AS THE LARGEST TWO WHEELER HERO HONDA IS SET TO END THE CURRENT FISCAL AS THE LARGEST TWO WHEELER COMPANY IN THE WORLD FOR THE FOURTH YEAR IN SUCCESSION.COMPANY IN THE WORLD FOR THE FOURTH YEAR IN SUCCESSION.
HERO GROUP COMPANY, HERO CYCLES, IS THE LARGEST COMPANY WITH ANNUAL HERO GROUP COMPANY, HERO CYCLES, IS THE LARGEST COMPANY WITH ANNUAL PRODUCTION OF 5.4 mn BICYCLESPRODUCTION OF 5.4 mn BICYCLES
ESSEL PROPACK IS THE WORLD`S LARGEST MANUFACTURER OF LAMINATED TUBES.ESSEL PROPACK IS THE WORLD`S LARGEST MANUFACTURER OF LAMINATED TUBES.
GLOBAL MARKETSHARE OF MORE THAN 30%, HAS MANUFACTURING FACILITIES IN GLOBAL MARKETSHARE OF MORE THAN 30%, HAS MANUFACTURING FACILITIES IN CHINA,USA,GERMANY,MEXICO,COLUMBIA, VENEZUELA, PHILIPPINES, INDONESIA, CHINA,USA,GERMANY,MEXICO,COLUMBIA, VENEZUELA, PHILIPPINES, INDONESIA, EGYPT AND NEPAL.EGYPT AND NEPAL.
BHARAT FORGE IS THE WORLD`S SECOND LARGEST COMPANYBHARAT FORGE IS THE WORLD`S SECOND LARGEST COMPANY
SUNDARAM FASTENERS IS THE WORLD`S THIRD LARGEST BRAKE LINING, FASTENER SUNDARAM FASTENERS IS THE WORLD`S THIRD LARGEST BRAKE LINING, FASTENER AND RADIATOR CAPS MANUFACTURERSAND RADIATOR CAPS MANUFACTURERS
TATA TEA AND ITS SUBSIDIARY TATA TETLEY TOGETHER CONSTITUTE THE SECOND TATA TEA AND ITS SUBSIDIARY TATA TETLEY TOGETHER CONSTITUTE THE SECOND LARGEST BRANDED PORTFOLIO IN THE WORLD.LARGEST BRANDED PORTFOLIO IN THE WORLD.
STRAND IN DEAL WITH US CO FOR MICROARRAY PLATFORM
HAS ENTERED INTO AN AGREEMENT WITH US MAJOR AFFYMETRIX, FOR PROVIDING MICROARRAY PLATFORM
MICROARRAYS ARE POWERFUL TOOLS THAT ALLOW SCIENTISTS TO MEASURE AND COMPARE THE EXPRESSION LEVELS OF THOUSANDS OF GENES IN A SINGLE EXPERIMENT.
CONTRACT RESEARCH AND CONTRACT RESEARCH AND AMNUFACTURING(CRAM)AMNUFACTURING(CRAM)
TCSTCS INFOSYSINFOSYS WIPROWIPRO HCL TECHNOLOGIESHCL TECHNOLOGIES ITTIAMITTIAM SASKENSASKEN BIOCONBIOCON SHASUNSHASUN DIVI`SDIVI`S
INDIAN MULTINATIONALSINDIAN MULTINATIONALS
MANY INDIAN COMPANIES IN DRAGON MANY INDIAN COMPANIES IN DRAGON COUNTRY !COUNTRY !
INFOSYS, TCS, SUNDARAM FASTENERS, INFOSYS, TCS, SUNDARAM FASTENERS, BHARAT FORGEBHARAT FORGE
RANBAXY NOW SELLS MORE ABROAD THAN RANBAXY NOW SELLS MORE ABROAD THAN IN INDIA IN INDIA
HAS SUBSIDIES IN MORE THAN 12 HAS SUBSIDIES IN MORE THAN 12 COUNTRIESCOUNTRIES
SHASUN HIKES CONTRACT THRUST
USFDA-COMPLAINT R&D (RESEARCH AND DEVELOPMENT) CENTRE NEAR CHENNAI AT AN INVESTMENT OF ABOUT RS.35 CRORE.
THE NEW FACILITY WOULD HOUSE ABOUT EIGHT LABORATORIES AND NEARLY 300 SCIENTISTS.
CCMB SPOTS GENETIC JACKPOT IN INDIA
WITH ITS 4,635 ANTHROPOLOGICALLY WELL-DEFINED ENDOGAMOUS POPULATIONS-OF WHICH 532 ARE TRIBES, INCLUDING 72 PRIMITIVE POPULATIONS, INDIA IS A BIGGER LABORATORY THAN ICELAND TO STUDY POPULATION/COMMUNITY-BASED GENETIC DISEASES.
BIOCON CHAIRMAN KIRAN MAZUMDAR-SHAW ARGUES THAT THE COUNTRY’S UNIQUE GENE POOLS ARE “GOLD MINES”.
ABOUT 50 MILLION INDIVIDUALS ARE AFFECTED WITH GENETIC DISEASES IN INDIA.
PEP PILL : SANDOZ INVESTS $13M IN THIRD FACILITY IN INDIA.
ROCHE DIAGNOSTICS EYES INDIA FOR PRODUCTION, R&D.